COMP <GO>
CVSA vs BAM // REVENUE GROWTH (YOY)
Covista Inc. (NYSE) VS. Brookfield Asset Management Inc Class A Limited Voting Shares (NYSE) • 15-METRIC TALLY: CVSA 4
— BAM 9
▲ REVENUE GROWTH (YOY) LEADER: BAM
LAST: $124.33 (-3.44%) • MKT CAP: $4.36B
revenue-growth
12.90%
BAM — Brookfield Asset Management Inc Class A Limited Voting Shares SUPERIOR
ROARABLE B • RQD 73/100
LAST: $48.26 (-0.70%) • MKT CAP: $77.63B
revenue-growth
16.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVSA VS. BAM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVSA | BAM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.90% | 41.00% | +15.90 | CVSA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.80% | 20.00% | -5.20 | BAM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.5x | 25.6x | -13.10 | CVSA | /valuation <GO> |
| Free Cash Flow Yield | 6.60% | 2.48% | +4.12 | CVSA | /fcf-yield <GO> |
| Operating Margin | 19.10% | 74.20% | -55.10 | BAM | /operating-margins <GO> |
| Net Profit Margin | 13.30% | 60.80% | -47.50 | BAM | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 12.90% | 16.70% | -3.80 | BAM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.40% | 3.63% | -0.23 | BAM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.73 | 7.93 | -3.20 | BAM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 7.10% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.0 | 61.1 | -18.10 | BAM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.06 | -0.01 | BAM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.5x | 27.2x | -11.70 | CVSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.36B | $77.63B | -$73.27B | BAM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVSA REV | BAM REV | CVSA GROSS % | BAM GROSS % | CVSA FCF | BAM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.79B | $3.94B | 56.9% | 44.0% | $287.6M | $1.92B |
| FY 2024 | $1.58B | $3.38B | 55.9% | 44.0% | $246.9M | $1.46B |
| FY 2023 | $1.45B | $3.14B | 44.0% | 44.0% | $126.6M | $1.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVSA // BETA 1.05
BAM // BETA 1.06